21160-40-7 Usage
Uses
Used in Pharmaceutical Synthesis:
1-(4-bromo-phenyl)-1-hydroxy-acetone is used as an intermediate for the synthesis of pharmaceuticals, contributing to the development of new drugs and therapeutic agents. Its unique structure allows for further chemical modifications and functionalization, which can lead to the creation of novel and effective medications.
Used in Agrochemical Production:
In the agrochemical industry, 1-(4-bromo-phenyl)-1-hydroxy-acetone is utilized as a key intermediate in the production of various agrochemicals, such as pesticides and herbicides. Its incorporation into these compounds can enhance their effectiveness in protecting crops and controlling pests.
Used in Organic Synthesis:
1-(4-bromo-phenyl)-1-hydroxy-acetone is employed as a reagent in organic synthesis, particularly in the preparation of heterocyclic compounds. Its presence in these reactions can facilitate the formation of complex molecular structures, which are essential in the development of new materials and chemicals.
Used in Drug Development:
As a valuable building block in organic chemistry, 1-(4-bromo-phenyl)-1-hydroxy-acetone is used in drug development to create new pharmaceutical compounds with potential therapeutic applications. Its unique structure and reactivity make it an attractive candidate for the design and synthesis of novel drugs targeting various diseases and conditions.
Check Digit Verification of cas no
The CAS Registry Mumber 21160-40-7 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 2,1,1,6 and 0 respectively; the second part has 2 digits, 4 and 0 respectively.
Calculate Digit Verification of CAS Registry Number 21160-40:
(7*2)+(6*1)+(5*1)+(4*6)+(3*0)+(2*4)+(1*0)=57
57 % 10 = 7
So 21160-40-7 is a valid CAS Registry Number.
21160-40-7Relevant academic research and scientific papers
Substituted heteroaryl amide modulators of glucocorticoid receptor, AP-1, and/or NF-kB activity and use thereof
-
Page/Page column 46, (2008/06/13)
The present invention relates to new class of non-steroidal compounds which are useful in treating diseases associated with modulation of the glucocorticoid receptor, AP-1, and/or NF-κB activity including obesity, diabetes, inflammatory- and immune-associ
